Article
Catechol-O-methyltransferase and breast cancer risk.
Carcinogenesis - 1 Nov 1998
Millikan R C, Pittman G S, Tse C K, Duell E, Newman B, Savitz D, Moorman P G, Boissy R J, Bell D A
Abstract excerpt
Recent studies suggest that a polymorphism in catechol-O-methyltransferase (COMT) is associated with increased risk of breast cancer. Methylation by COMT is the principal pathway for inactivation of catechol estrogens, which are hypothesized to participate in estrogen-induced carcinogenesis. We examined the association of COMT genotype and breast cancer risk in a population-based, case-control study of invasive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
